Relay Therapeutics Names Ben Wolf Chief Medical Officer

Xconomy Boston — 

Relay Therapeutics has appointed Ben Wolf to serve as chief medical officer, the same position he held most recently at KSQ Therapeutics. His experience also includes positions at Blueprint Medicines (NASDAQ: BPMC), Merrimack Pharmaceuticals (NASDAQ: MACK), ImmunoGen, Amgen (NASDAQ: AMGN), and Genentech. Last year, Cambridge, MA-based Relay raised $400 million for its work developing cancer drugs based on an understanding of how the shape of a protein plays a role in disease.